中證網訊（記者 楊澎(peng)）微芯生物（688321）8月13日晚間(jian)公(gong)告稱，公(gong)司股(gu)(gu)東(dong)萍鄉永智英華元豐投(tou)資(zi)合伙(huo)企業(有限合伙(huo))計(ji)劃減(jian)持(chi)公(gong)司股(gu)(gu)份(fen)，數量(liang)不(bu)超過2832.2萬股(gu)(gu)，即(ji)不(bu)超過公(gong)司總股(gu)(gu)本(ben)的6.91%；公(gong)司一致行動人股(gu)(gu)東(dong)LAV One (Hong Kong) Co., Limited與Vertex Technology Fund (III) Ltd計(ji)劃減(jian)持(chi)公(gong)司股(gu)(gu)份(fen)不(bu)超過1230萬股(gu)(gu)，即(ji)不(bu)超過公(gong)司總股(gu)(gu)本(ben)的3%。